• Article

Patient Preferences for Frequency of Glucagon-Like Peptide-1 Receptor Agonist (Glp-1Ra) Injections in the Treatment of Type 2 Diabetes

Citation

Hauber, A., Nguyen, H., Posner, J., Ervin, C., Larue, S., & Kalsekar, I. (2014). Patient Preferences for Frequency of Glucagon-Like Peptide-1 Receptor Agonist (Glp-1Ra) Injections in the Treatment of Type 2 Diabetes. Value in Health, 17(3), A255-A255.